Artur Świerczek

A Novel, Pan-PDE Inhibitor Exerts Anti-Fibrotic Effects in Human Lung Fibroblasts via Inhibition of TGF-β Signaling and Activation of cAMP/PKA Signaling

Katarzyna Wójcik‐Pszczoła, Grażyna Chłoń‐Rzepa, Agnieszka Jankowska et al. · International Journal of Molecular Sciences · 2020 · 50 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Novel butanehydrazide derivatives of purine-2,6-dione as dual PDE4/7 inhibitors with potential anti-inflammatory activity: Design, synthesis and biological evaluation

Grażyna Chłoń‐Rzepa, Agnieszka Jankowska, Marietta Ślusarczyk et al. · European Journal of Medicinal Chemistry · 2018 · 46 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain

Grażyna Chłoń‐Rzepa, Marietta Ślusarczyk, Agnieszka Jankowska et al. · European Journal of Medicinal Chemistry · 2018 · 36 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT1A/5-HT7 receptor antagonists and phosphodiesterase 4/7 inhibitors with procognitive and antidepressant activity

Agnieszka Jankowska, Grzegorz Satała, Marcin Kołaczkowski et al. · European Journal of Medicinal Chemistry · 2020 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases

Veronika Ručilová, Artur Świerczek, David Vanda et al. · European Journal of Medicinal Chemistry · 2020 · 25 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14